Division of Endocrinology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
Diabetes Metab Res Rev. 2017 Oct;33(7). doi: 10.1002/dmrr.2909. Epub 2017 Jun 16.
Women with a history of gestational diabetes are at high risk for developing type 2 diabetes mellitus. In studies with long periods of follow-up, diabetes incidence of up to 70% has been reported. The appropriate follow-up of women following a pregnancy complicated by gestational diabetes has not been studied. Published guidelines recommend that obstetrician/gynaecologists, who are often the de facto primary care physicians for these otherwise healthy young women, incorporate glucose monitoring in the post-partum period into their annual examinations. In reality, reported rates of screening have been low. There is also no clear evidence for any beneficial interventions to prevent diabetes in patients with prior history of gestational diabetes. Lifestyle intervention programmes for diabetes prevention among these patients yielded disappointing results. Metformin, pioglitazone, liraglutide, and bariatric surgery are possible options but based on inadequate data. There remains a need for randomized, placebo-controlled studies to evaluate various pharmacologic treatments, with and without lifestyle interventions, to prevent type 2 diabetes mellitus in women with a history of gestational diabetes.
有妊娠糖尿病病史的女性发生 2 型糖尿病的风险很高。在随访时间较长的研究中,报告的糖尿病发病率高达 70%。对于妊娠合并妊娠糖尿病的女性,尚未对其进行适当的随访。已发表的指南建议,妇产科医生通常是这些健康年轻女性事实上的初级保健医生,应将产后期间的血糖监测纳入其年度检查中。但实际上,筛查的报告率很低。对于既往有妊娠糖尿病史的患者,也没有明确的证据表明任何有益的干预措施可以预防糖尿病。针对这些患者的糖尿病预防生活方式干预计划的结果令人失望。二甲双胍、吡格列酮、利拉鲁肽和减重手术可能是选择,但基于数据不足。仍需要随机、安慰剂对照研究来评估各种药物治疗,包括和不包括生活方式干预,以预防有妊娠糖尿病病史的女性发生 2 型糖尿病。